Welcome to our dedicated page for Rocket Lab Usa SEC filings (Ticker: RKLB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Rocket Lab Corporation (Nasdaq: RKLB) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as a U.S. public company. These documents include current reports on Form 8-K, proxy statements, and other filings that describe material events, governance matters, capital markets activity, and acquisitions.
Rocket Lab’s Form 8-K filings cover topics such as quarterly financial results, executive and director changes, equity offering arrangements, and significant transactions. Examples include reports of results of operations for specific quarters, the adoption of a senior executive cash incentive bonus plan, the establishment of an at-the-market equity offering program under a shelf registration statement, and the completion or announcement of acquisitions such as the purchase of the parent holding company of GEOST LLC and an agreement to acquire all shares of Mynaric AG.
The company’s proxy statement on Form DEF 14A provides detail on board structure, director elections, executive compensation, equity plans, and stockholder voting matters. It also describes the holding company reorganization that made Rocket Lab Corporation the parent of Rocket Lab USA, Inc., and outlines proposals presented to stockholders at the annual meeting.
Through these filings, investors can review information about capital raising (including at-the-market offerings), governance and compensation policies, acquisition terms, and other material corporate events. Real-time updates from EDGAR allow users to see new 8-Ks and related exhibits as they are filed.
Stock Titan’s platform associates these filings with AI-powered summaries that explain the key points of lengthy documents, helping users quickly identify items such as new financing arrangements, changes in leadership, or the structure of significant transactions. Users can also track how Rocket Lab uses registration statements and resale prospectus supplements in connection with share issuances tied to acquisitions.
Rocket Lab Corporation disclosed a major change to CEO Sir Peter Beck’s compensation. Effective March 30, 2026, his annual base salary under his existing employment agreement is voluntarily reduced to $1.00 or the New Zealand statutory minimum. He will also have no expectation of any annual bonus or target bonus, and waives any claim that these changes trigger a breach of his employment agreement or Good Reason under the Executive Severance Plan.
On the same date, Beck entered an RSU cancellation agreement, voluntarily forfeiting all unvested restricted stock units representing 392,155 shares of Rocket Lab common stock. The company states that, at his request, capital previously allocated to this compensation will be redirected to company priorities and strategic R&D initiatives, underscoring a focus on long‑term shareholder value over short‑term incentives.
Rocket Lab Corp’s major shareholder Sir Peter Beck and related entities updated their ownership disclosure and trading plans. Beck and the Equatorial Trust group beneficially own 46,443,180 shares of common stock, or about 7.51% of Rocket Lab’s outstanding shares as of March 20, 2026.
On March 27, 2026, the Trust adopted a Rule 10b5-1 trading plan with Goldman Sachs & Co. LLC to sell up to 5,000,000 shares of Rocket Lab common stock, after a required cooling-off period and before the plan’s July 8, 2026 expiration. These potential sales, just over 10% of Beck’s direct and indirect holdings, are for diversification, estate planning and philanthropic purposes.
On March 30, 2026, Beck voluntarily cancelled unvested restricted stock units covering 392,155 shares, allowing that foregone compensation to be redirected to company priorities and strategic R&D. Over the prior 60 days, he sold 18,857 shares in open-market “sell-to-cover” transactions on March 2, 2026 to satisfy tax withholding on vesting RSUs.
Rocket Lab Corporation will hold its virtual Annual Meeting of Stockholders on May 20, 2026 at 1:30 p.m. Pacific Daylight Time to vote on director election, ratification of Deloitte & Touche LLP, a non-binding say-on-pay advisory vote, and a subsidiary merger to remove a pass-through voting provision.
The record date is March 30, 2026. The company reports 45,951,250 shares of Series A Convertible Participating Preferred Stock outstanding voting together with Common Stock on an as-converted one-for-one basis. Proxy access, virtual participation, and voting instructions are provided at www.virtualshareholdermeeting.com/rklb2026.
Rocket Lab Corp (RKLB): Amendment to Schedule 13G/A from The Vanguard Group. The filing states that following an internal realignment effective January 12, 2026, certain Vanguard subsidiaries will report beneficial ownership separately. The Vanguard Group reports 0 shares beneficially owned and 0% of Rocket Lab common stock as of this amendment. The filing is signed by Ashley Grim, Head of Global Fund Administration, dated 03/27/2026.
Kampani Arjun reported acquisition or exercise transactions in this Form 4 filing.
Rocket Lab Corp reported that SVP & General Counsel Arjun Kampani received a grant of 77,189 shares of common stock in the form of restricted stock units under the company’s 2021 Stock Option and Incentive Plan. After this award, he holds 475,177 shares directly.
The RSUs will vest over time: 1/16 vests on March 1, 2028 and 1/16 vests on each March 1, May 22, August 22, and November 22 thereafter, as long as he continues in service through each vesting date.
Rocket Lab Corp Chief Financial Officer Adam C. Spice reported a bona fide gift of 1,558 shares of Common Stock. The transfer was recorded at a price of $0.00 per share, reflecting a non-market, no‑consideration gift transaction. Following this disposition, he continues to hold 1,295,266 shares directly, indicating that the gifted amount represents a small portion of his overall stake.
Rocket Lab Corporation entered into an equity distribution agreement that allows it to offer and sell, from time to time, shares of its common stock with an aggregate offering price of up to $1,000,000,000.
Sales may be made through multiple investment banks as sales agents or principals, and via complex forward sale structures. These include “Initially Priced Forward Transactions” and “Collared Forward Transactions,” where forward purchasers borrow and sell shares to hedge their exposure and Rocket Lab later settles in cash or stock. The program runs off an effective Form S-3 shelf registration and can be terminated at any time by Rocket Lab or the sales agents.
Rocket Lab Corporation is registering and may sell up to $1,000,000,000 of its common stock via an "at-the-market" equity distribution agreement with multiple sales agents and related forward sale structures.
The prospectus supplement terminates a prior $750,000,000 sales agreement and permits sales through sales agents acting as agents or principals, as well as forward transactions ("initially priced" and "collared" forwards) with specified forward purchasers. Proceeds from initially priced and collared forward transactions are expected to be received on physical settlement or certain prepayment dates; cash or net-share settlement is possible and may result in payments by Rocket Lab or issuance of shares. Commissions to sales agents and forward sellers may be up to 2.0%. The company’s common stock trades on Nasdaq under the symbol RKLB; last reported sale price was $71.31 per share on March 16, 2026.
Rocket Lab Corporation plans to hold its 2026 annual meeting of stockholders on May 20, 2026. Because this date is more than 30 days earlier than the 2025 meeting anniversary, the company has set a new deadline for stockholder proposals and director nominations.
Stockholder proposals submitted under Rule 14a-8 and any director nominations or other business brought under the company’s bylaws must be received by the Company’s Secretary at its Long Beach, California headquarters by March 22, 2026 to be considered for the 2026 proxy materials and meeting.
Rocket Lab Corp director Merline Saintil reported an open-market sale of common stock. On the reported date, she sold 18,126 shares at a weighted-average price of $75.0398 per share in multiple transactions within a narrow price range.
After this sale, Saintil directly holds 261,903 Rocket Lab common shares. The filing notes that the reported price reflects a weighted average and that detailed trade prices within the $75.0000–$75.0950 range are available upon request.